Cellular MR imaging

Molecular Imaging

Volumn 4, Issue 3, 2005, Pages 143-164

  Modo, Michel ^a   Hoehn, Mathias ^b   Bulte, Jeff W M ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell labeling; Gadolinium; Macrophage; MR contrast agent; Stem cells; Superparamagnetic iron oxide; Transplantation

Indexed keywords

CELL CULTURE; CELLS; GADOLINIUM; IMMUNOLOGY; IRON OXIDES;

CELL LABELING; MR CONTRAST AGENTS; STEM CELLS; SUPERMAGNETIC IRON OXIDE;

MAGNETIC RESONANCE IMAGING;

ANIMAL; CELL; CELL TRANSPLANTATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ANIMALS; CELL TRANSPLANTATION; CELLS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 27244435218     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/15353500200505145     Document Type: Review

References (187)

1. Runge VM (2000). Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging. 12:205-213.
2. Breslau J, Jarvik JG, Haynor DR, Longstreth WT Jr., Kent DL, Maravilla KR (1999). MR contrast media in neuroimaging: A critical review of the literature. AJNR Am J Neuroradiol. 20: 670-675.
3. Clement O, Siauve N, Lewin M, de Kerviler E,Cuenod CA, Frija G (1998). Contrast agents in magnetic resonance imaging of the liver: Present and future. Biomed Pharmacother. 52:51-58.
4. Mandeville JB, Moore J, Chesler DA, Garrido L, Weissleder R, Weisskoff RM (1997). Dynamic liver imaging with iron oxide agents: Effects of size and biodistribution on contrast. Magn Reson Med 37:885-890.
5. Montet X, Lazeyras F, Howarth N, Mentha G, Rubbia-Brandt L, Backer CD, Vallee JP, Terrier F (2004). Specificity of SPIO particles for characterization of liver hemangiomas using MRI. Abdom Imaging 29:60-70.
6. Kim MJ, Kim JH, Lim JS, Oh YT, Chung JJ, Choi JS, Lee WJ, Kim KW (2004), Detection and characterization of focal hepatic lesions: Mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging, 20: 612-621.
7. Reimer P, Balzer T (2003). Ferucarbotran (Resovist): A new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications. Eur Radial. 13:1266-1276.
8. Macarini L, Marini S, Murrone M, Ettorre GC (2004). Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: Clinical findings and classification according to pathogenesis. Radial Med (Torino). 108:92-106.
9. Clement O, Siauve N, Cuenod CA, Frija G (1998). Liver imaging with ferumoxides (Feridex): Fundamentals, controversies, and practical aspects. Top Magn Reson Imaging. 9:167-182.
10. Reimer P, Bader A, Weissleder R (1998). Preclinical assessment of hepatocyte-targeted MR contrast agents in stable human liver cell cultures. J Magn Reson Imaging. 8:687-689.
11. van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE (1999). Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther. 290: 153-157.
12. Clement O, Muhler A, Vexler V, Berthezene Y, Brasch RC (1992). Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Invest Radial. 27:612-619.
13. Yoshikawa K, Inoue Y, Akahane M, Shimada M, Itoh S, Seno A, Hayashi S (2003). Phantom and animal studies of a new hepatobiliary agent for MR imaging: Comparison of Gd-DTPA-DeA with Gd-EOB-DTPA. J Magn Reson Imaging. 18:204-209.
14. Hsu JS, Jaw TS, Liu GC, Wang YM, Chen SH, Kuo YT, Jao JC, Li CW, Tsai KB (2004). Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: An animal study. J Magn Reson Imaging. 20:632-639.
15. Liou J, Lee JK, Borrello JA, Brown, JJ (1994). Differentiation of hepatomas from nonhepatomatous masses: Use of MnDPDP-enhanced MR images. Magn Reson Imaging. 12:71-79.
16. Talwalkar JA, Gores GJ (2004). Diagnosis and staging of hepato-cellular carcinoma. Gastroenterology. 127:S126-S132.
17. 2-weighted MR cholangiography. Radiology. 233: 659-666.
18. Muhler A, Preise CE, Kuwatsuru R, Rosenau W, Liu T, Mintorovitch J, Clement O, Vexler V, Mahboubi S, Lang P (1993). Acute liver rejection: Evaluation with cell-directed MR contrast agents in a rat transplantation model. Radiology. 186:139-146.
19. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT (1988). Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver. Radiology. 168:297-301.
20. Weissleder R (1994). Liver MR imaging with iron oxides: Toward consensus and clinical practice. Radiology. 193:593-595.
21. Weissleder R, Heautot JF, Schaffer BK, Nossiff N, Papisov MI, Bogdanov A Jr., Brady TJ (1994). MR lymphography: Study of a high-efficiency lymphotrophic agent. Radiology. 191:225-230.
22. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ (1990). Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology. 175:494-498.
23. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003). Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 348:2491-2499.
24. Seneterre E, Weissleder R, Jaramillo D, Reimer P, Lee AS, Brady TJ, Wittenberg J (1991). Bone marrow: Ultrasmall superparamagnetic iron oxide for MR imaging. Radiology. 179: 529-533.
25. Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M (2003). Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: Enhancement by tissue necrosis factor-alpha, interleukin-lbeta, and interferon-gamma. Circulation. 107: 1545-1549.
26. Rogers WJ, Basu, P (2005). Factors regulating macrophage endocytosis of nanoparticles: Implications for targeted magnetic resonance plaque imaging. Atherosclerosis. 178:67-73.
27. Pratten MK, Lloyd JB (1986). Pinocytosis and phagocytosis: The effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim Biopbys Acta. 881:307-313.
28. Rogers JM, Jung CW, Lewis J, Groman EV (1998). Use of USPIO-induced magnetic susceptibility artifacts to identify sentinel lymph nodes and lymphatic drainage patterns: I. Dependence of artifact size with subcutaneous Combidex dose in rats. Magn Reson Imaging. 16:917-923.
29. Xu S, Jordan EK, Brocke S, Bulte JW, Quigley L, Tresser N, Ostuni JL, Yang Y, McFarland HF, Frank JA (1998). Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: Early histopathological correlation. J Neurosci Res. 52:549-558.
30. Dousset V, Delalande C, Ballarino L, Quesson B, Seilhan D, Coussemacq M, Thiaudiere E, Brochet B, Canioni P, Caille JM (1999). In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med. 41:329-333.
31. 1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am J Neuroradiol. 20:223-227.
32. Rausch M, Hiestand P, Baumann D, Cannet C, Rudin M (2003). MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med. 50:309-314.
33. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA (2004). Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol. 55:654-659.
34. Rausch M, Hiestand P, Foster CA, Baumann DR, Cannet C, Rudin M (2004). Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: Clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging. 20:16-24.
35. Rausch M, Baumann D, Neubacher U, Rudin M (2002). In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed. 15:278-283.
36. Rausch M, Sauter A, Frohlich J, Neubacher U, Radu EW, Rudin M (2001). Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med. 46:1018-1022.
37. Kleinschnitz C, Bendszus M, Frank M, Solymosi L, Toyka KV, Stoll G (2003). In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. J Cereb Blood Flow Metab. 23:1356-1361.
38. Weber R, Wegener S, Ramos-Cabrer P, Wiedermann D, Hoehn M (in press). MRI detection of macrophage activity after experimental stroke in rats: New indicators for late appearance of vascular degradation? Magn Reson Med.
39. Schroeter M, Saleh A, Wiedermann D, Hoehn M, Jander S (2004). Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia. Magn Reson Med. 52:403-406.
40. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, Modder U, Jander S (2004). In vivo MRI of brain inflammation in human ischaemic stroke. Brain. 127:1670-1677.
41. Hauger O, Delalande C, Trillaud H, Deminiere C, Quesson B, Kahn H, Cambar J, Combe C, Grenier N (1999). MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome. Magn Reson Med. 41:156-162.
42. Hauger O, Delalande C, Deminiere C, Fouqueray B, Ohayon C, Garcia S, Trillaud H, Combe C, Grenier N (2000). Nephrotoxic nephritis and obstructive nephropathy: Evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide - preliminary findings in a rat model. Radiology. 217: 819-826.
43. Leroy-Willig A, Fromes Y, Paturneau-Jouas M, Carlier P (2003). Assessing gene and cell therapies applied in striated skeletal and cardiac muscle: Is there a role for nuclear magnetic resonance? Neuromuscul Disord. 13:397-407.
44. Beckmann N, Falk R, Zurbrugg S, Dawson J, Engelhardt P (2003). Macrophage infiltration into the rat knee detected by MRI in a model of antigen-induced arthritis. Magn Reson Med. 49: 1047-1055.
45. Kresse M, Wagner S, Thode KLD, Semmler W (1998). MR plaque imaging using superparamagnetic iron oxide particles. Proc Int Soc Magn Reson Med. 6:633.
46. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF (2001). Magnetic-resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 103:415-422.
47. Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B (2001). Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging. 14:355-361.
48. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM (2003). Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 107:2453-2458.
49. Zhang Y, Dodd SJ, Hendrich KS, Williams M, Ho C (2000). Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. Kidney Int. 58: 1300-1310.
50. Beckmann N, Cannet C, Fringeli-Tanner M, Baumann D, Pally C, Bruns C, Zerwes HG, Andriambeloson E, Bigaud M (2003). Macrophage labeling by SPIO as an early marker of allograftchronic rejection in a rat model of kidney transplantation. Magn Reson Med. 49:459-467.
51. Kanno S, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C (2000). A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg. 120:923-934.
52. Kanno S, Wu YJ, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C (2001). Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation, 104:934-938.
53. Aime S, Cabella C, Colombatto S, Geninatti Crich S, Gianolo E, Maggioni F (2002). Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imaging. 16:394-406.
54. Jacobs RE, Fraser SE (1994). Magnetic resonance microscopy of embryonic cell lineages and movements. Science. 263: 681-684.
55. Papan C, Boulat B, Fraser SE, Jacobs RE (2004). Longitudinal study of early xenopus embryonic development using 3D-microscopic MRI. Proc Int Soc Magn Reson Imaging Med. 12:578.
56. Jacobs RE, Ahrens ET, Meade TJ, Fraser SE (1999). Looking deeper into vertebrate development. Trends Cell Biol. 9:73-76.
57. Hüber MM, Staubli AB, Kustedjo K, Gray MH, Shih J, Fraser SE, Jacobs RE, Meade TJ (1998). Fluorescently detectable magnetic resonance imaging agents. Bioconjug Chem. 9:242-249.
58. Modo M, Cash D, Mellodew K, Williams SC, Fraser SE, Meade TJ, Price J, Hodges H (2002). Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage. 17:803-811.
59. Modo M, Mellodew K, Cash D, Fraser SE, Meade TJ, Price J, Williams SC (2004). Mapping transplanted stem cell migration after a stroke: A serial, in vivo magnetic resonance imaging study. Neuroimage. 21:311-317.
60. Crich SG, Biancone L, Cantaluppi V, Duo D, Esposito G, Russo S, Camussi G, Aime S (2004). Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn Reson Med. 51:938-944.
61. Daldrup-Link HE, Rudelius M, Metz S, Piontek G, Pichler B, Settles M, Heinzmann U, Schlegel J, Oostendorp RA, Rummeny EJ (2004), Cell tracking with gadophrin-2: A bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. Eur J Nucl Med Mol Imaging. 31:1312-1321.
62. Josephson L, Kircher M, Mahmood U, Tang Y, Weissleder R (2002). Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem. 13:554-560.
63. Aime S, Carrera C, Delli Castelli D, Geninatti Crich S, Terreno E (2005). Tunable imaging of cells labeled with MRI-PARACEST agents. Angew Chem Int Ed Engl. 44:1813-1815.
64. Snoussi K, Bulte JW, Gueron M, van Zijl PC (2003). Sensitive CEST agents based on nucleic acid imino proton exchange: Detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med. 49: 998-1005.
65. Goffeney N, Bulte JW, Duyn J, Bryant LH Jr., van Zijl PC (2001). Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. J Am Chem Soc. 123:8628-8629.
66. Shikata F, Tokumitsu H, Ichikawa H, Fukumori Y (2002). In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur J Pharm Biopharm. 53:57-63.
67. Alauddin MM, Louie AY, Shahinian A, Meade TJ, Conti PS (2003). Receptor mediate uptake of a radiolabeled contrast agent sensitive to α-galactosidase activity. Nucl Med Biol. 30: 261-265.
68. Allen MJ, Meade TJ (2003). Synthesis and visualization of a membrane-permeable MRI contrast agent. J Biol Inorganic Chem. 8:746-750.
69. Allen MJ, MacRenaris KW, Venkatasubramanian PN, Meade TJ (2004). Cellular delivery of MRI contrast agents. Chem Biol. 11:301-307.
70. Kayyem JF, Kumar RM, Fraser SE, Meade TJ (1995). Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem Biol. 2:615-620.
71. Bhorade R, Weissleder R, Nakakoshi T, Moore A, Tung CH (2000). Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem. 11:301-305.
72. Rudelius M, Daldrup-Link HE, Heinzmann U, Pointek G, Settles M, Link TM, Schlegel J (2003). Highly efficient paramagnetic-labelling of embryonic and neuronal stem cells. EurJ Nucl Med Mol Imaging. 30:1038-1044.
73. Heckl S, Debus J, Jenne J, Pipkorn R, Waldeck W, Spring H, Rastert R, von der Lieth C, Braun K (2002). CNN-Gd3+ enables cell nucleus molecular imaging of prostate cancer cells: The last 600 nm. Cancer Res. 62:7018-7024.
74. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ (2000). In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol. 18:321-325.
75. Aoki I, Tanaka C, Takegami T, Ebisu T, Umeda M, Fukunaga M, Fukuda K, Silva AC, Koretsly AP, Naruse S (2002). Dynamic activity-induced manganese-dependent contrast magnetic resonance imaging (DAIM MRI). Magn Reson Med 48: 927-933.
76. Leergaard TB, Bjaalie JG, Devor A, Wald LL, Dale AM (2003). In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing. Neuroimage. 20:1591-1600.
77. Pautler RG, Koretsky AP (2002). Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage. 16:441-448.
78. Van der Linden A, Verhoye M, Van Meir V, Tindemans I, Eens M, Absil P, Balthazart J (2002). In vivo manganese-enhanced magnetic resonance imaging reveals connections and functional properties of the songbird vocal control system. Neuroscience. 112:467-474.
79. Aoki I, Takahashi Y, Chuang K-H, Igarashi T, Silva AC, Tanaka C, Childs RW, Koretsky AP (2004). In vitro cell labeling for manganese enhanced magnetic resonance imaging. Proc Intl Soc Mag Res Med. 12:164.
80. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH (2003). Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 50:293-302.
81. Podulso JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ, Jack CR Jr (2002). Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis. 11:315-329.
82. Cohen B, Dafni H, Meir G, Neeman M (2004), Ferritin as novel MR-reporter for molecular imaging of gene expression. Proc Int Soc Magn Reson Med. 11:1707.
83. Mikawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y, Miwa N, Shinohara H (2001). Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug Chem. 12:510-514.
84. Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S, Rosenbrock H, Keller U, Heinzmann U, Rummeny EJ, Schlegel J, Link TM (2003). Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 228:760-767.
85. Yeh TC, Zhang W, Ildstad ST, Ho C (1993). Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn Reson Med. 30:617-625.
86. Sipe JC, Filippi M, Martino G, Furlan R, Rocca MA, Rovaris M, Bergami A, Zyroff J, Scotti G, Comi G (1999). Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging. 17: 1521-1523.
87. Zelivyanskaya ML, Nelson JA, Poluektova L, Uberti M, Mellon M, Gendelman HE, Boska MD (2003). Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J Neurosci Res. 73:284-295.
88. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr (1997). Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging. 7:258-263.
89. Moore A, Weissleder R, Bogdanov A Jr (1997). Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging. 7:1140-1145.
90. Franklin RJ, Blaschuk KL, Bearchell MC, Prestoz LL, Setzu A, Brindle KM, Ffrench-Constant C (1999). Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. NeuroReport. 10:3961-3965.
91. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C (2002). Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl AcadSci USA. 99:16267-16272.
92. van den Bos EJ, Wagner A, Mahrholdt H, Thompson RB, Morimoto Y, Sutton BS, Judd RM, Taylor DA (2003). Improved efficacy of stem cell labeling for magnetic resonance imaging studies by the use of cationic liposomes. Cell Transplant. 12: 743-756.
93. Bulte JW, Arbab AS, Douglas T, Frank JA (2004). Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol. 386:275-299.
94. Bulte JWM, Ma LD, Magin RL, Kamman RL, Hulstaert CE, Go KG, The TH, de Leij L (1993). Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med. 29:32-37.
95. Bulte JWM, Laughlin PG, Jordan EK, Tran VA, Vymazal J, Frank JA (1996). Tagging of T cells with superparamagnetic iron oxide: Uptake kinetics and relaxometry. Acad Radial. 3:301-303.
96. Josephson L, Tung CH, Moore A, Weissleder R (1999). High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem. 10: 186-191.
97. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol. 18:410-414.
98. Kaufman CL, Williams M, Ryle LM, Smith TL, Tanner M, Ho C (2003). Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labeling for in vivo magnetic resonance imaging detection of cell migration: Uptake and durability. Transplantation. 76: 1043-1046.
99. Dodd CH, Hsu H, Chu W, Yang P, Zhang H, Mountz JD, Zinn K, Forder J, Josephson L, Weissleder R, Mountz JM, Mountz JD (2001). Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptidederived superparamagnetic nanoparticles. J Immunol Methods. 256:89-105.
100. Zhao M, Kircher MF, Josephson L, Weissleder R (2002). Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem. 13:840-844.
101. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY (1984). Transferrin receptor on endothelium of brain capillaries. Nature. 312:162-163.
102. Bulte JWM, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA (1999). Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA. 96:15256-15261.
103. Bulte JWM, Ben-Hur T, Miller BR, Mizrachi-Kol R, Einstein O, Reinhartz E, Zywicke HA, Douglas T, Frank JA (2003). MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magn Reson Med. 50:201-205.
104. Moore A, Josephson L, Bhorade R, Basilion JP, Weissleder R (2001). Human transferrin receptor gene as a marker gene for MR imaging. Radiology. 221:244-250.
105. Berry CC, Charles S, Wells S, Dalby MJ, Curtis AS (2004). The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture. Int J Pharm. 269: 211-225.
106. Ahrens ET, Feili-Hariri M, Xu H, Genove G, Morel PA (2003). Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med. 49:1006-1013.
107. Strable E, Bulte JWM, Moskowitz BM, Vivekanadan K, Allen M, Douglas T (2001). Synthesis and characterization of soluble iron oxide-dendrimer complexes. Chem Mater. 13:2201-2209.
108. Bulte JWM, Douglas T, Witwer B, Zhang S-C, Lewis B (2001). Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol. 19: 1141-1147.
109. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalio DA, Baker JR (1996). Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA. 93:4897-4902.
110. Tang MX, Redemann CT, Szoka FC Jr (1996). In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem. 7:703-714.
111. Bryant LH Jr., Bulte JWM (2001). Denfrimers: Chemical principles and biotechnology applications. In M, de Cuyper & J.W.M. Bulte (Eds.), Focus on Biotechnology, (vol. 7, pp 47-69). Dordrecht: Kluwer Academic Publishing.
112. Zhang Z-Y, Smith BD (2000). High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: Membrane bending model. Bioconjug Chem. 11:805-814.
113. Bulte JWM, Lu J, Zywicke H, van Gelderen P, Douglas T, McDonald JW, Frank JA (2001). 3D MR tracking of magnetically labeled embryonic stem cells transplanted in the contusion injured rat spinal cord. Proc Int Soc Magn Reson Med. 9:130.
114. Bulte JWM, Douglas T, van Gelderen P, Lewis BK, Frank JA (2001). Cellular imaging using magnetodendrimers: Application to human stem cells and neoplastic cells in vivo. Proc Int Soc Magn Reson Med. 9:52.
115. Hakumaki JM, Savitt JM, Gearhart JD, Dawson TM, Dawson VL, Bulte JWM (2001). MRI detection of labeled neural progenitor cells in a mouse model of Parkinson's disease. Dev Brain Res. 132:43-44.
116. Hakumaki JM, Bulte JWM, Shamblott MI, Zhang J, Douglas T, van Zijl PCM, Gearhart JD, Kerr D (2004). Magnetic resonance imaging of murine EG-derived neural stem cells in mouse lower motor neuron paralysis. Proc Int Soc Mag Reson Med. 12.
117. Lee IH, Bulte JW, Schweinhardt P, Douglas T, Trifunovski A, Hofstetter C, Olson L, Spenger C (2004). In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol. 187:509-516.
118. Walter GA, Kahili KS, Huard J, Feng H, Douglas T, Sweeney HL, Bulte JW (2004). Noninvasive monitoring of stem cell transfer for muscle disorders. Magn Reson Med. 51:273-277.
119. Wilhelm C, Gazeau F, Roger J, Pons JN, Bacri JC (2002). Interaction of anionic superparamagnetic nanoparticles with cells: Kinetic analysis of mebrane adsorption and subsequent internalization. Langmuir. 18:8148-8155.
120. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F (2003). Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials. 24:1001-1011.
121. Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, Gazeau F (2003). Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging. Magn Reson Med. 49:646-654.
122. Wilhelm C, Gebers A, Bacri JC, Gazeau F (2003). Deformation of intracellular endosomes under a magnetic field. Eur Biophys J. 32:655-660.
123. Frank JA, Miller BR, Arbab AS, Zywickie HA, Jordan EK, Lewis BK, Bryant LH Jr., Bulte JW (2003). Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology. 228:480-487.
124. Frank JA, Zywickie HA, Jordan EK, Mitchell J, Lewis BK, Miller B, Bryant LH Jr., Bulte JW (2002). Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol. 9:484-487.
125. Kalish H, Arbab AS, Miller BR, Lewis BK, Zywickie HA, Bulte JW, Bryant LH Jr., Frank JA (2003). Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med. 50: 275-282.
126. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA (2004). Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood. 104:1217-1223.
127. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW (2003). In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 107:2290-2293.
128. Cahill KS, Silver X, Gaidosh G, Byrne BJ, Walter GA (2003). Noninvasive monitoring and tracking of muscle stem cells. Proc Int Soc Magn Reson Med. 11:368.
129. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine H, Frank J (2005). Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood. 105:420-425.
130. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW (2004). Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 17:513-517.
131. Shen WC, Ryser HJ (1978). Conjugation of poly-L-lysine to albumin and horseradish peroxidase: A novel method of enhancing the cellular uptake of proteins. Proc Natl Acad Sci USA. 75: 1872-1876.
132. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA (2003). Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agents for cellular imaging. Radiology. 229:838-846.
133. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF (2004). Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood. 104: 3410-3412; author reply 3412-3413.
134. Jendelova P, Herynek V, DeCroos J, Glogarova K, Andersson B, Hajek M, Sykova E (2003). Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med. 50:767-776.
135. Shapiro EM, Skrtic S, Koretsky AP (2005). Sizing it up: Cellular MRI using micron-sized iron oxide particles. Magn Reson Med. 53:329-338.
136. Ray DE, Cavanagh JB, Nolan CC, Williams SC (1996). Neurotoxic effects of gadopentetate dimeglumine: Behavioral disturbance and morphology after intracerebroventricular injection in rats. AJNR Am J Neuroradiol. 17:365-373.
137. Dobson AW, Erikson KM, Aschner M (2004). Manganese neurotoxicity. Ann N YAcad Sci. 1012:115-128.
138. Pautler RG (2004). In vivo, trans-synaptic tract-tracing utilizing manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed. 17:595-601.
139. Zhang ZG, Jiang Q, Zhang R, Zhang L, Wang L, Zhang L, Arniego P, Ho KL, Chopp M (2003). Magnetic resonance imaging and neurosphere therapy of stroke in rat. Ann Neural. 53:259-263.
140. Zhang RL, Zhang L, Zhang ZG, Morris D, Jiang Q, Wang L, Zhang LJ, Chopp M (2003). Migration and differentiation of adult rat subventricular zone progenitor cells transplnated into the adult rat striatum. Neuroscience. 116:373-382.
141. Dick AJ, Guttman MA, Raman VK, Peters DC, Hill JM, Pessanha BS, Scott G, Smith S, McVeigh ER, Ledermab RJ (2003). Realtime MRI enables targeted injection of labeled stem cells to the border of recent porcine myocardial infarction based on functional and tissue characteristics. Proc Int Soc Magn Reson Med. 11:365.
142. Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ, Dunbar CE, McVeigh ER, Lederman RJ (2003). Serial cardiac magnetic-resonance imaging of injected mesenchymal stem cells. Circulation. 108:1009-1014.
143. Sorger JM, Despres D, Schimel D, McVeigh ER, Hill JM (2003). MRI tracking of stem cell homing to myocardial infarction. Proc Int Soc Magn Reson Med. 11:364.
144. Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA, Varney TR, Balaban RS, Koretsky AP, Dunbar CE (2003). Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood. 102:867-872.
145. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP (2004). MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA. 101:10901-10906.
146. Himmelreich U, Weber R, Ramos-Cabrer P, Wegener S, Kandal K, Shapiro EM, Koretsky AP, Hoehn M (2005). Improved stem cell MR detectability in animal models by modification of the inhalation gases. Mol Imaging. 4:1-6.
147. Pirko I, Johnson A, Ciric B, Gamez J, Macura S, Pease L, Rodriguez M (2004). In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J. 18:179-182.
148. Pirko I, Ciric B, Johnson A, Gamez J, Rodriguez M, Macura S (2003). Magnetic resonance imaging of immune cells in inflammation of central nervous system. Croat Med J. 44: 463-468.
149. Dunning MD, Lakatos A, Loizou L, Kettunen M, ffrench-Constant C, Brindle K, Franklin R (2004). Superparamagnetic iron oxide-labeled schwann cells and
150. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG (1997). Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data. Magn Reson Med. 38:389-398.
151. Chen YI, Brownell AL, Galpern W, Isacson O, Bogdanov M, Beal MF, Livini E, Rosen BR, Jenkins BG (1999). Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET, and behavioral assessment. Neuro-Report. 10:2881-2886.
152. Sandhu JK, Roberts TJ, Price J, Meade TJ, Williams SCR, Modo M (2004). A quantitative comparison of unilateral versus bilateral neural stem cell transplantation in the 3-nitroproprionic acid model of Huntington's disease by contrast agent-enhanced MRI. Proc Int Soc Magn Reson Med. 12:2420.
153. Zhang Z, Jiang Q, Jiang F, Ding G, Zhang R, Wang L, Zhang L, Robin AM, Katakowski M, Chopp M (2004). In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage. 23:281-287.
154. Modo M, Roberts TJ, Sandhu JK, Williams SCR (2004). In vivo monitoring of cellular transplants by magnetic resonance imaging and positron emission tomography. Exp Opin Biol Ther. 4:145-155.
155. Garot J, Unterseeh T, Teiger E, Champagne S, Chazaud B, Gherardi R, Hittinger L, Gueret P, Rahmouni A (2003). Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. J Am Coll Cardiol. 41:1841-1846.
156. Himes N, Min JY, Lee R, Brown C, Shea J, Huang X, Xiao YF, Morgan JP, Burstein D, Oettgen P (2004). In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med. 52:1214-1219.
157. Kuestermann E, Roell W, wecker S, Wiedermann D, Buehrle C, Welz A, Hescheler J, Fleischmann BK, Hoehn M (2003). Stem cell implantation into ischemic heart: A high-resolution magnetic resonance investigation. Proc Int Soc Magn Reson Med. 11:804.
158. 1 relaxation in rat myocardium. Magn Reson Med. 52:506-514.
159. Weber A, Pedrosa I, Kawamoto A, Himes N, Munasinghe J, Asahara T, Rofsky NM, Losordo DW (2004). Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease. Eur J Cardiothorac Surg. 26:137-143.
160. Frangioni JV, Hajjar RJ (2004). In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation. 110: 3378-3383.
161. Mahmood U (2004). Can MR imaging be used to track delivery of intravascularly administered stem cells? Radiology. 233:625-626.
162. Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JW, Moonen CT, Ripoche J, Grenier N (2004). In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology. 233:781-789.
163. Hauger O et al (in press). MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology.
164. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R (2003). In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 63:6838-6846.
165. Daldrup-Link HE, Meier R, Rudelius M, Piontek G, Piert M, Metz S, Settles M, Uherek C, Wels W, Schlegel J, Rummeny EJ (2005). In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol. 15:4-13.
166. Daldrup-Link HE, Rudelius M, Piontek G, Metz S, Braurer R, Debus G, Corot C, Schlegel Link TM, Peschel C, Rummeny EJ, Oostendorp RA (2005). Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: In vivo monitoring with 1.5-T MR imaging equipment. Radiology. 234: 197-205.
167. Askensay N, Farkas DL (2002). Optikal imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells. 20:501-513.
168. Fox D, Kouris GJ, Blumofe KA, Heilizer TJ, Husak V, Greisler HP (1999). Optimizing fluorescent labeling of endothelial cells for tracking during long-term studies of autologous transplantation. J Surg Res. 86:9-16.
169. Ferrari A, Hannouche D, Oudina K, Bourguignon M, Meunier A, Sedel L, Petite H (2001). In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye. J Biomed Mater Res. 56:361-367.
170. Oh DJ, Lee GM, Francis K, Palsson BO (1999). Phototoxicity of the fluorescent membrane dyes PKH2 and PKH26 on the human hematopoietic KG1a progenitor cell line. Cytometry. 36:312-318.
171. Contag CH, Bachmann MH (2002). Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng. 4:235-260.
172. Rice BW, Cable MD, Nelson MB (2001). In vivo imaging of light-emitting probes. J Biomed Opt. 6:432-440.
173. Koransky ML, Ip TK, Wu S, Cao Y, Berry G, Contag C, Blau H, Robbins R (2001). In vivo monitoring of myoblast transplantation into rat myocardium. J Heart Lung Transplant. 20:188-189.
174. Kim D-E, Schellingerhout D, Ishii K, Shah K, Weissleder R (2004). Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke. 35:952-957.
175. Tang Y, Shah K, Messerli SM, Synder E, Breakefield X, Weissleder R (2003). In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther. 14:1247-1254.
176. Costa GL, Sandora M, Nakajima A, Nguyen E, Taylor-Edwards C, Slavin A, Contag C, Garrison Fathman C, Benson J (2001). Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol. 167:2379-2387.
177. Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH (2001). Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol. 29:1353-1360.
178. Marzullo P (2004). Nuclear imaging after cell implantation. Int J Cardiol. 95:853-54.
179. Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG (2001). Positron emission tomography-based imaging of transgene expression mediated by replication - conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res. 61: 2983-2995.
180. Ding W, Bai J, Zhang J, Chen Y, Cao L, He Y, Shen L, Wang F, Tian J (2004). In vivo tracking of implanted stem cells using radio-labeled transferrin scintigraphy. Nucl Med Biol. 31: 719-725.
181. Bai J, Ding W, Yu M, Du J, Liu Z, Jia B, Li L, Shen L, Tian J, Wang F (2004). Radionuclide imaging of mesenchymal stem cells transplanted into spinal cord. NeuroReport. 15:1117-1120.
182. Chin BB, Nakamoto Y, Bulte JW, Pittenger MF, Wahl R, Kraitchman DL (2003). 111 In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun. 24:1149-1154.
183. Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, Riviere I, Sadelain M, O'Reilly RJ, Larson SM, Tjuvajev JG (2003). Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol. 21:405-413.
184. Dubey P, Su H, Adonai N, Du S, Rosato A, Braun J, Gambhir SS, Witte ON (2003). Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci USA. 100:1232-1237.
185. Wu JC, Chen IY, Sundaresan G, Min JJ, De A, Qiao JH, Fishbein MC, Gambhir SS (2003). Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation. 108: 1302-1305.
186. de Vries I, Lesterhuis W, Barentsz J, Gambarota G, Scheenen T, Scharenborg N, Veltien A, Rijntjes J, Boerman O, Oyen W, Adema G, van Krieken J, Bulte JWM, Punt C, Heerschap A, Figdor C (2005). MR tracking of magnetically labeled dendritic cells migrating to lymph nodes in melanoma patients: First clinical experience. Proc Int Soc Magn Reson Med. 13:2603.
187. Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR, Gearhart JD (1998). Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA. 95:13726-13731.